About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
COMPANY NEWS
Company
News
Cipla Ltd.
Change Company
BSE Code
500087
ISIN Demat
INE059A01026
Book Value
411.56
NSE Code
CIPLA
Dividend Yield %
1.05
Market Cap
1225550.48
P/E
22.54
EPS
67.31
Face Value
2
1 Week
1 Month
3 Months
6 Months
1 Year
11-Dec-2025
Cipla moves up on launching ‘Yurpeak’
10-Dec-2025
Cipla launches ‘Yurpeak’
05-Dec-2025
Cipla completes acquisition of 100% stake in Inzp...
05-Dec-2025
Cipla gains on completing acquisition of 100% sta...
04-Dec-2025
Cipla launches therapy for Knee Osteoarthritis ‘C...
04-Dec-2025
Cipla gains on launching therapy for Knee Osteoar...
29-Nov-2025
Cipla launches integrated lung diagnostics, welln...
04-Nov-2025
Cipla to acquire Inzpera Healthsciences
30-Oct-2025
Cipla reports 4% rise in Q2 consolidated net prof...
30-Oct-2025
Cipla informs about financial results
23-Oct-2025
Cipla enters into agreement with Eli Lilly and Co...
23-Oct-2025
Cipla informs about product launch
12-Sep-2025
Cipla informs about revision in ESG rating
28-Aug-2025
Cipla’s arm recalling over 20,000 packs of Ibuter...
28-Aug-2025
Cipla trades higher on the BSE
Page
1
of
3
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.